| Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer C Rolfo, P Mack, GV Scagliotti, C Aggarwal, ME Arcila, F Barlesi, T Bivona, ... Journal of Thoracic Oncology 16 (10), 1647-1662, 2021 | 421 | 2021 |
| Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer U Malapelle, R Sirera, E Jantus-Lewintre, P Reclusa, S Calabuig-Fariñas, ... Expert review of molecular diagnostics 17 (3), 209-215, 2017 | 184 | 2017 |
| CBX7 is a tumor suppressor in mice and humans F Forzati, A Federico, P Pallante, A Abbate, F Esposito, U Malapelle, ... The Journal of clinical investigation 122 (2), 2012 | 169 | 2012 |
| The evolving landscape of biomarker testing for non-small cell lung cancer in Europe KM Kerr, F Bibeau, E Thunnissen, J Botling, A Ryška, J Wolf, K Öhrling, ... Lung Cancer 154, 161-175, 2021 | 162 | 2021 |
| EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment A Friedlaender, V Subbiah, A Russo, GL Banna, U Malapelle, C Rolfo, ... Nature reviews Clinical oncology 19 (1), 51-69, 2022 | 144 | 2022 |
| Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients U Malapelle, C Mayo de-Las-Casas, D Rocco, M Garzon, P Pisapia, ... British Journal of Cancer 116 (6), 802-810, 2017 | 127 | 2017 |
| SMO gene amplification and activation of the hedgehog pathway as novel mechanisms of resistance to anti-epidermal growth factor receptor drugs in human lung cancer CM Della Corte, C Bellevicine, G Vicidomini, D Vitagliano, U Malapelle, ... Clinical cancer research 21 (20), 4686-4697, 2015 | 123 | 2015 |
| Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models R Rosa, R Marciano, U Malapelle, L Formisano, L Nappi, C D'Amato, ... Clinical cancer research 19 (1), 138-147, 2013 | 119 | 2013 |
| The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal V Gristina, U Malapelle, A Galvano, P Pisapia, F Pepe, C Rolfo, S Tortorici, ... Cancer Treatment Reviews 85, 101994, 2020 | 116 | 2020 |
| Liquid biopsy and lung cancer P Pisapia, U Malapelle, G Troncone Acta cytologica 63 (6), 489-496, 2019 | 116 | 2019 |
| PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine? N Fusco, E Sajjadi, K Venetis, G Gaudioso, G Lopez, C Corti, EG Rocco, ... Genes 11 (7), 719, 2020 | 113 | 2020 |
| Next generation sequencing techniques in liquid biopsy: focus on non-small cell lung cancer patients U Malapelle, P Pisapia, D Rocco, R Smeraglio, M di Spirito, C Bellevicine, ... Translational lung cancer research 5 (5), 505, 2016 | 111 | 2016 |
| Ion Torrent next-generation sequencing for routine identification of clinically relevant mutations in colorectal cancer patients U Malapelle, E Vigliar, R Sgariglia, C Bellevicine, L Colarossi, D Vitale, ... Journal of clinical pathology 68 (1), 64-68, 2015 | 109 | 2015 |
| Challenges and opportunities of cfDNA analysis implementation in clinical practice: Perspective of the International Society of Liquid Biopsy (ISLB) C Rolfo, AF Cardona, M Cristofanilli, L Paz-Ares, JJD Mochon, I Duran, ... Critical Reviews in Oncology/Hematology 151, 102978, 2020 | 105 | 2020 |
| Noninvasive biomarkers of colorectal cancer: role in diagnosis and personalised treatment perspectives G Pellino, G Gallo, P Pallante, R Capasso, A De Stefano, I Maretto, ... Gastroenterology research and practice 2018 (1), 2397863, 2018 | 99 | 2018 |
| PIK3CA Mutations as a Molecular Target for Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer N Fusco, U Malapelle, M Fassan, C Marchiò, S Buglioni, S Zupo, ... Frontiers in Oncology 11, 644737, 2021 | 98 | 2021 |
| Next-generation sequencing of lung cancer EGFR exons 18-21 allows effective molecular diagnosis of small routine samples (cytology and biopsy) D de Biase, M Visani, U Malapelle, F Simonato, V Cesari, C Bellevicine, ... PloS one 8 (12), e83607, 2013 | 97 | 2013 |
| The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review … A Galvano, V Gristina, U Malapelle, P Pisapia, F Pepe, N Barraco, ... ESMO open 6 (3), 100124, 2021 | 96 | 2021 |
| Immunotherapy in non-small cell lung cancer harbouring driver mutations A Addeo, A Passaro, U Malapelle, GL Banna, V Subbiah, A Friedlaender Cancer treatment reviews 96, 102179, 2021 | 95 | 2021 |
| Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases U Malapelle, P Pisapia, R Sgariglia, E Vigliar, M Biglietto, C Carlomagno, ... Journal of clinical pathology 69 (9), 767-771, 2016 | 92 | 2016 |
Pasquale PisapiaUniversity of Naples Federico IIEmail verificata su unina.it
